Literature DB >> 19481833

Structural and biological properties of a papillary component generating a micropapillary component in lung adenocarcinoma.

Tatsuya Nagano1, Genichiro Ishii, Kanji Nagai, Takeo Ito, Akikazu Kawase, Kenji Takahashi, Yoshihiro Nishimura, Yutaka Nishiwaki, Atsushi Ochiai.   

Abstract

Lung adenocarcinoma with a micropapillary component (MPC) is an aggressive subtype of adenocarcinoma with a papillary component. The aim of this study was to explore the pathobiological properties of a papillary component which generates MPC. We reviewed the 445 cases of resected primary lung adenocarcinoma and confirmed all of the MPC(+) cases (n=150) were found only in the cases of adenocarcinoma with a papillary component (n=228) and no features of the MPC were detected in any of the other histological subtypes without papillary component. Even in the cases of adenocarcinoma with a papillary component, the MPC(+) group (n=150) had significantly poorer outcome than the MPC(-) group (n=78) (P<0.0001). When this MPC(+) cases were divided into grade 0-2 according to the proportion of the tumor occupied by the MPC, the stage I patients with grade 2 MPC had a significantly poorer outcome than the stage I patients with grade 0 or grade 1 MPC. By considering the histological characteristics that MPC has always structural continuity with papillary component, we evaluated the pathobiological profile of (1) MPC, (2) papillary component which generate MPC [PC MPC(+)], and (3) papillary component without MPC [PC MPC(-)]. The mean width of the stalks in the PC MPC(+) was significantly smaller than in the PC MPC(-) (17.64+/-9.53 vs. 26.07+/-10.16mum, P<0.001). Although staining for CD34 and collagen IV showed that MPC lacked both fibrovascular stalks and basement membranes, staining for cleaved caspase 3 showed that apoptotic cells were rare in the MPC (1.0%), and the expression levels of the adhesion molecules E-cadherin, beta-catenin, and CD44 were similar in all three lesions. The immunohistochemical staining scores of hypoxic marker GLUT-1 in the MPC, PC MPC(+), and PC MPC(-) were 69, 26, and 8.6, respectively, and the differences between the MPC and PC MPC(+) and between the PC MPC(+) and PC MPC(-) were significant (P=0.001 and 0.025, respectively). These results indicated that the biological behavior of the papillary component which generates MPC is different from the papillary component without MPC in terms of structural alternation and hypoxic state, and the difference may be related to the aggressive behavior of MPC(+) adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481833     DOI: 10.1016/j.lungcan.2009.04.014

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  11 in total

1.  Stromal micropapillary pattern predominant lung adenocarcinoma--a report of two cases.

Authors:  Miki Ohe; Tomoyuki Yokose; Yuji Sakuma; Sachie Osanai; Chikako Hasegawa; Kota Washimi; Kimitoshi Nawa; Tetsukan Woo; Rurika Hamanaka; Haruhiko Nakayama; Yoichi Kameda; Kouzo Yamada; Takeshi Isobe
Journal:  Diagn Pathol       Date:  2011-09-29       Impact factor: 2.644

2.  Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.

Authors:  Jun-ichi Nitadori; Adam J Bograd; Kyuichi Kadota; Camelia S Sima; Nabil P Rizk; Eduardo A Morales; Valerie W Rusch; William D Travis; Prasad S Adusumilli
Journal:  J Natl Cancer Inst       Date:  2013-08-07       Impact factor: 13.506

3.  Micropapillary component in gastric adenocarcinoma: an aggressive variant associated with poor prognosis.

Authors:  Qingfu Zhang; Jian Ming; Siyang Zhang; Bo Li; Liying Yin; Xueshan Qiu
Journal:  Gastric Cancer       Date:  2014-02-22       Impact factor: 7.370

Review 4.  Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts.

Authors:  Ming-Ching Lee; Kyuichi Kadota; Daniel Buitrago; David R Jones; Prasad S Adusumilli
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

5.  The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.

Authors:  Takashi Eguchi; Kyuichi Kadota; Bernard J Park; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  Semin Thorac Cardiovasc Surg       Date:  2014-09-16

6.  Papillary Renal Cell Carcinomas Demonstrating Micropapillary Features: An Investigation Into the Diagnostic and Prognostic Implications.

Authors:  Beatriz Caraballo; Maha Abdulla; Sunder Sham; Guang-Qian Xiao; Pamela Unger
Journal:  Cureus       Date:  2022-05-12

7.  Recent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomas.

Authors:  Ming-Ching Lee; Daniel H Buitrago; Kyuichi Kadota; David R Jones; Prasad S Adusumilli
Journal:  Lung Cancer Manag       Date:  2014-06-01

8.  Clinical and pathologic prognostic factors that are influential in the survival and prognosis of lung adenocarcinomas and invasive predominant subtypes.

Authors:  Arife Zeybek; Serap Toru; Irem Hicran Ozbudak; Alpay Sarper; Necdet Oz; Hakan Bozcuk; Gülay Ozbilim; Abid Demircan
Journal:  Int Surg       Date:  2013 Jul-Sep

9.  HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast.

Authors:  Sophie Doublier; Dimas C Belisario; Manuela Polimeni; Laura Annaratone; Chiara Riganti; Elena Allia; Dario Ghigo; Amalia Bosia; Anna Sapino
Journal:  BMC Cancer       Date:  2012-01-04       Impact factor: 4.430

10.  Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma.

Authors:  Miki Ohe; Tomoyuki Yokose; Yuji Sakuma; Yohei Miyagi; Naoyuki Okamoto; Sachie Osanai; Chikako Hasegawa; Haruhiko Nakayama; Yoichi Kameda; Kouzo Yamada; Takeshi Isobe
Journal:  Diagn Pathol       Date:  2012-01-06       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.